CDKN2A and Miyoshi myopathy: By deleting this domain, viral replication can only proceed in cells with a defective retinoblastoma (RB) pathway, an almost universal abnormality in human malignancies, including MM in which mutations affecting this pathway, such as deletion of the CDKN2A locus encoding the RB upstream regulator p16, is among the most common (24).